Camolotto Soledad A, Belova Veronika K, Snyder Eric L
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Department of Pathology, University of Utah, Salt Lake City, UT, USA.
J Gastrointest Oncol. 2018 Dec;9(6):1005-1013. doi: 10.21037/jgo.2018.05.04.
Over the last decade, multiple genomics studies have led to the identification of discrete molecular subtypes of pancreatic ductal adenocarcinoma. A general theme has emerged that most pancreatic ductal adenocarcinoma (PDAC) can be grouped into two major subtypes based on cancer cell autonomous properties: classical/pancreatic progenitor and basal-like/squamous. The classical/progenitor subtype expresses higher levels of lineage specifiers that regulate endodermal differentiation than the basal-like/squamous subtype. The basal-like/squamous subtype confers a worse prognosis, raising the possibility that loss of these lineage specifiers might enhance the malignant potential of PDAC. Here, we discuss several of these differentially expressed lineage specifiers and examine the evidence that they might play a functional role in PDAC biology.
在过去十年中,多项基因组学研究已导致鉴定出胰腺导管腺癌的不同分子亚型。一个普遍的主题已经出现,即大多数胰腺导管腺癌(PDAC)可根据癌细胞自主特性分为两种主要亚型:经典/胰腺祖细胞型和基底样/鳞状型。经典/祖细胞亚型比基底样/鳞状亚型表达更高水平的调节内胚层分化的谱系特异性因子。基底样/鳞状亚型预后较差,这增加了这些谱系特异性因子的缺失可能增强PDAC恶性潜能的可能性。在这里,我们讨论其中几种差异表达的谱系特异性因子,并研究它们可能在PDAC生物学中发挥功能作用的证据。